nanotech investing Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
nanotech investing Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
nanotech investing Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process
nanotech investing Universal Ibogaine advises further on application for Management Cease Trade Order
Syntholene Engages Imperial College of London Expert for Independent Technical Review of Operating Data from Iceland Demonstration Facility
QIMC Ties New Salem-Apple River Helium Zones to a Buried Basement Structure: Gravity, Magnetics and Geochemistry Converge on a Single Fault-Bounded Ramp
